ProGraME: A novel flow cytometry algorithm for the diagnosis of low-risk myelodysplastic syndromes in patients with cytopenia.

Jesper TherkelsenDicte Wilhjelm TraedenIda SchjødtMette Klarskov AndersenLene Dissing SjöJakob Werner Hansen Kirsten Grønbaek Konstantinos Dimopoulos

Published in: European journal of haematology (2023)

ProGraME can potentially optimize the FC diagnosis of low-risk myelodysplasia without minimal requirements of flow analysis other than accurate population gating.

Keyphrases

flow cytometry
machine learning
deep learning